There were errors in the Funding statement. The correct statement is "This work was supported by grants from the SingHealth Foundation (http://www.singhealth.com.sg), National Medical Research Council (http://www.nmrc.gov.sg), Biomedical Research Council of Singapore and The Singapore Millennium Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Citation: Xia H, Ooi LLPJ, Hui KM (2012) Correction: MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma. PLoS ONE 7(9): 10.1371/annotation/1be2a62e-45a1-4c13-9a8d-f265005a21e0. doi:10.1371/annotation/1be2a62e-45a1-4c13-9a8d-f265005a21e0
Published: September 28, 2012
Copyright: © 2012 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests: No competing interests declared.